MDFA launches new economic modelling
My Eyes offers a new way to support AMD patients.
Evaluation of MDFA’s education courses for health professionals
A successful project to train practitioners to screen for diabetic eye disease in Indigenous communities across Australia has been extended.
A years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.
Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia
MDFA 2022 research update
MDFA welcomed Dr Kathy Chapman as CEO in July
Attend any medical congress and you’ll increasingly hear the terms “artificial intelligence” and “digital diagnosis”